CDEK
← All drugs Report issue

zinc gluconate

Small moleculeexperimental

Zinc gluconate is the zinc salt of gluconic acid. It is an ionic compound consisting of two anions of gluconate for each zinc(II) cation. Zinc gluconate is a popular form for the delivery of zinc as a dietary supplement providing 14.35% elemental zinc by weight. — Wikipedia

Clinical trial activity

18 trials · 21 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
5
Phase 3
4
Phase 4
2

Earliest trial started Jan 31, 2013 (NCT01783353)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • ZincSupplementation

    Zinc supplementation

Chemistry & pharmacology

Loading structure…

SMILES

O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Zn+2]
Mol. weight
455.68 g/mol
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06577285N/AJun 1, 2024Cairo University
NCT06290219Phase 3Mar 20, 2024Taichung Veterans General Hospital
NCT05892770Phase 1/Phase 2 (Phase 2)Aug 1, 2023University of Florida
NCT05305872Phase 4Jan 1, 2023Anhui Medical University
NCT05597137Phase 2Nov 30, 2022Southern Medical University
NCT05527899Phase 2/Phase 3 (Phase 3)May 3, 2022National Heart, Lung, and Blood Institute (NHLBI), Tufts University
NCT04641195Phase 3Apr 22, 2021Foundation for Medical Research, Harvard University, University of Toronto
NCT04558424N/AOct 1, 2020Bangladesh Medical University
NCT05098678N/AAug 22, 2020Tabriz Medical University
NCT04351490N/AApr 30, 2020University of Lille
NCT04342728N/AApr 8, 2020The Cleveland Clinic
NCT05085834Early Phase 1 (Phase 1)Jan 22, 2020Case Western Reserve University
NCT03957720Early Phase 1 (Phase 1)Mar 15, 2019Zhejiang University
NCT05096312Phase 4Dec 21, 2018East Avenue Medical Center, Philippines
NCT03421314N/ASep 1, 2016Instituto Nacional de Enfermedades Respiratorias
NCT03898102Phase 2Mar 31, 2016Chang Gung University
NCT02475928N/AApr 30, 2015Fundación Clínica Médica Sur
NCT01783353Phase 2/Phase 3 (Phase 3)Jan 31, 2013Philippine Dermatological Society
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (21)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Anhui Medical UniversityAcademic/Hospital1112023
Bangladesh Medical UniversityAcademic/Hospital1112020
Cairo UniversityAcademic/Hospital1112024
Case Western Reserve UniversityAcademic/Hospital1112020
Chang Gung UniversityAcademic/Hospital1112016
East Avenue Medical Center, PhilippinesAcademic/Hospital1112018
Foundation for Medical ResearchAcademic/Hospital1012021
Fundación Clínica Médica SurAcademic/Hospital1112015
Harvard UniversityAcademic/Hospital1112021
Instituto Nacional de Enfermedades RespiratoriasAcademic/Hospital1112016
National Heart, Lung, and Blood Institute (NHLBI)Government1012022
Philippine Dermatological SocietyAcademic/Hospital1112013
Southern Medical UniversityAcademic/Hospital1112022
Tabriz Medical UniversityAcademic/Hospital1112020
Taichung Veterans General HospitalAcademic/Hospital1112024
The Cleveland ClinicAcademic/Hospital1112020
Tufts UniversityAcademic/Hospital1112022
University of FloridaAcademic/Hospital1112023
University of LilleAcademic/Hospital1112020
University of TorontoAcademic/Hospital1012021
21 organizations
Page 1 / 2